Repros Therapeutics Inc.の業績推移

Repros Therapeutics Inc.【RPRX】業績・財務データ

市場

NASDAQ

フォロー

Repros Therapeutics Inc.【RPRX】業績・財務データ

市場

NASDAQ

損益計算書

バランスシート／貸借対照表

キャッシュフロー計算書

CSVダウンロード

	2020/12/31	2021/12/31	2022/12/31
Cash collections from financial royalty assets	2,122	2,316	2,507
Cash collections from intangible royalty assets	144	151	73
Other royalty cash collections
Distributions from equity method investees
Interest received
Derivative collateral received
Derivative collateral posted
Termination payments on derivative instruments
Development-stage funding payments - ongoing
Development-stage funding payments - upfront and milestone
Payments for operating and professional costs
Interest paid
Net cash provided by operating activities
Distributions from equity method investees
Investments in equity method investees
Purchases of equity securities
Proceeds from equity securities
Purchases of available for sale debt securities
Proceeds from available for sale debt securities
Purchases of marketable securities
Proceeds from Sale and Maturity of Marketable Securities
Acquisitions of financial royalty assets
Acquisitions of other financial assets
Milestone payments
Net cash used in investing activities
Distributions to shareholders/unitholders
Distributions to legacy non-controlling interests - royalty receipts
Distributions to legacy non-controlling interests - other
Distributions to continuing non-controlling interests
Dividends to shareholders
Contributions from legacy non-controlling interests - R&D
Proceeds From Noncontrolling Interests, Other
Scheduled repayments of long-term debt
Repayments of long-term debt
Proceeds from Issuance of Long-Term Debt
Debt issuance costs and other
Proceeds from Issuance Initial Public Offering
Net cash (used in)/provided by financing activities
Net change in cash and cash equivalents

アプリでもっと便利に